The COVID-19 pandemic has presented new challenges and created questions about what life in the office will look like going forward.
Read More Insight Categories
The basics and the process of drug approval
The COVID-19 pandemic has put the spotlight on the FDA drug approval process. Why will it take so long for a vaccine to get approved?
Read More
During a crisis, moving drugs to market requires a strong HVAC strategy
As the global pandemic brings new attention to emerging therapies, the biopharmaceutical industry shouldn’t overlook HVAC design for contamination control.
Read More
6 considerations for scaling up an industrial biotechnology process
Industrial biotechnology processes face a unique set of challenges when it comes to scale-up.
Read More
Preventing the next pandemic: mRNA vaccines and siRNA oligo therapies
Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.
Read More
4 strategies of successful project execution
A lean approach to project execution relies on four steps for success.
Read More
Viral vectors—beyond the yellow brick road
The science of viral vector manufacturing is generating a lot of excitement, and companies in this space are under pressure to move fast and make cost-effective decisions; this can occasionally result in speed at the expense of due diligence.
Read More
Vaccines—our best long-term defense
Not a treatment, but a cure, vaccines are extremely important because they help us develop lifelong immunity to diseases.
Read More
Multimodal ATMP facilities to satisfy growing demand
Multimodal manufacturing optimizes product combinations based on manufacturing and regulatory similarity and compatibility. Manufacturers must produce a variety of Advanced Therapy Medicinal Products (ATMPs) quickly and efficiently. Why not design a multi-modal ATMP facility?
Read More
The greatest hazard for incubator labs? Inadequately managed hazardous chemicals
Developers creating multi-tenant spaces for life science startups need to consider something most other industries don’t: how hazardous chemicals play a role in their tenants’ work and the design of the building.
Read More